CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: Alnylam’s heart drug troubles take center stage at a cardiology conference

ConferenceNeutral
AI Analysis

Summary

Alnylam Pharmaceuticals' heart drug will be a focus at the European Society of Cardiology Congress in Munich starting August 28, 2026. The company views this conference as consequential for its cardiology program.

Importance:5/10
Sentiment:
0.00
cardiologyheart diseaseconference
Related Companies

Read the original article

Published by STAT News on August 27, 2026 10:30 AM

Read Original